interleukin 2

(redirected from Proleukin)
Also found in: Medical.
Related to Proleukin: Aldesleukin

interleukin 2


n.
a T-cell protein that stimulates the production of more T cells and other immune defenses: used experimentally in immunotherapy. Abbr.: IL-2
[1980–85]
References in periodicals archive ?
In this trial, 15 adult patients with CMML will receive Ceplene in conjunction with low-dose Proleukin (interleukin-2).
M2 EQUITYBITES-February 20, 2017-Immune Pharmaceuticals Inc to begin Overall Survival clinical study of Ceplene combined with low dose Proleukin in patients with Acute Myeloid Leukemia (AML)
Proleukin (aldesleukin; Novartis): Which two barriers do more doctors experience with Proleukin than any other brand?
Participants were assigned at random to receive either HAART alone or HAART plus subcutaneous Proleukin over several 5-day cycles.
Two major studies investigate the effect of IL-2: ESPRIT (Evaluation of Subcutaneous Proleukin in a Randomized International Trial) and SILCAAT (Subcutaneous IL-2 in HIV-infected Patients with Low CD4 Counts under Active Antiretroviral Therapy).
Finally, Proleukin, in phase III trials from the Chiron Corporation, is a synthetic copy of a protein (IL-2) that is produced by human T-cells.
M2 PHARMA-February 20, 2017-Immune Pharmaceuticals Inc to begin Overall Survival clinical study of Ceplene combined with low dose Proleukin in patients with Acute Myeloid Leukemia (AML)
The global kidney cancer drugs market report estimates the market size (Revenue USD million - 2013 to 2020) for key market segments based on the drug type (brand) such as Afinitor (everolimus), Avastin (bevacizumab), Inlyta (axitinib), Nexavar (sorafenib), Proleukin (aldesleukin), Sutent (sunitinib), Torisel (temsirolimus), Votrient (pazopanib), clinical phase 1, 2 and 3 drugs (AGS-003, Cabozantinib, Dovitinib, Keytruda, Opdivo) pipeline analysis, and forecasts growth trends (CAGR% - 2016 to 2020).
Proleukin (aldesleukin; Prometheus): Which three barriers do more doctors experience with Proleukin than any other brand?
Proleukin remains the only therapy to deliver durable remissions in metastatic renal cell carcinoma and metastatic melanoma.
Proleukin (aldesleukin; Novartis): Proleukin's team gets high performance and satisfaction scores in most areas.